Home › Geographic Atrophy › Arizona › Phoenix
Geographic Atrophy clinical trials in Phoenix, AZ
3 studies for Geographic Atrophy are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
RecruitingPhase 1/2
- Associated Retina Consultants, Phoenix
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- Barnet Dulaney Perkins Eye Center, Phoenix
- Associated Retina Consultants, Phoenix
- Retinal Research Institute, Phoenix
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
RecruitingPhase 2
- Associated Retina Consultants, Phoenix
Geographic Atrophy trials in other cities
- Dallas, TX8 studies
- Reno, NV8 studies
- Austin, TX7 studies
- Santa Monica, CA7 studies
- Cleveland, OH6 studies
- Houston, TX6 studies
- The Woodlands, TX6 studies
- Naperville, IL6 studies
- Baltimore, MD6 studies
- Spokane, WA5 studies
- Erie, PA5 studies
- Washington, DC5 studies
Other studies in Phoenix
- Breast Cancer25 studies
- Colorectal Cancer25 studies
- Obesity22 studies
- Non-Small Cell Lung Cancer20 studies
- Metastatic Cancer20 studies
- Heart Failure18 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Multiple Myeloma16 studies
- Pancreatic Cancer16 studies
- Cardiovascular Disease16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.